Aralia binnatifida (Seem.) Clarke.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | A. pseudo-ginseng Wall. ssp. himalaicus Hara. |
| Family | Araliaceae. |
| Habitat | Nepal, Sikkim and Bhutan, Khasi Hills. |
| Folk | Taapamaari (Maharashtra). |
| Action | Stimulant, aphrodisiac, antipyretic, dyspeptic, expectorant. |
| Taxonomic Cohort | Genus Aralia (1 documented species); Family Araliaceae (5 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Aralia binnatifida (taxonomically cited with authority (Seem.) Clarke.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Araliaceae (primary family classification: Araliaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. pseudo-ginseng Wall. ssp. himalaicus Hara, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Nepal, Sikkim and Bhutan, Khasi Hills.
Across classical and vernacular Indian systems of medicine, Aralia binnatifida is recognized under distinct polyglot nomenclature: in regional Indian folk and vernacular ethnobotany as Taapamaari (Maharashtra). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aralia binnatifida are: Stimulant, aphrodisiac, antipyretic, dyspeptic, expectorant. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
The therapeutic activity of Aralia binnatifida is grounded in its documented pharmacological actions (Stimulant, aphrodisiac, antipyretic, dyspeptic, expectorant) and the characteristic secondary metabolite profile of the family Araliaceae.
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Aralia binnatifida stands as a distinct representative of the genus Aralia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Araliaceae encompasses 5 documented medicinal species (0.28% of the 1,814-species flora). Other representative medicinal members of Araliaceae include: Hedera helix (Common Ivy), Hedera nepalensis (Nepal Ivy), Panax pseudoginseng (In Indian medicine), Polyscias fruticosa. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 5 medicinal species of family Araliaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Aralia binnatifida follow the plant-part modalities specified under its therapeutic action (Stimulant, aphrodisiac, antipyretic, dyspeptic, expectorant), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aralia binnatifida integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.